bearish

Sam Chun Dang Pharm: Block Deal Sale of Nearly 300 Billion Won by the CEO

371 Views26 Mar 2026 01:56
On 24 March, the CEO of Sam Chun Dang Pharm (Chun In-Seok) announced that he plans to sell 265,700 common shares in after-hours trading from 23 April to 22 May.
What is covered in the Full Insight:
  • CEO Stake Sale Announcement
  • Shareholder Structure
  • Performance and Market Position
  • Product Pipeline and Strategic Developments
  • Valuation and Competitive Analysis
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
chart-bar
x